EUVIMEDEUVIMED entdecken
Crossref

LEADS – a comprehensive human liver-on-a-chip for non-alcoholic steatohepatitis (NASH) drug testing

Gowri Manohari Balachander, Inn Chuan Ng, Roopesh R Pai, Kartik Mitra, Farah Tasnim, Yee Siang Lim, Royston Kwok, Yoohyun Song, Lai Ping Yaw, Clarissa Bernice Quah, Junzhe Zhao, Wahyunia L Septiana und 7 weitere

Lab on a Chip · 2025 · 25 (14) · 3444-3466

DOI: 10.1039/d5lc00221d ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lab on a Chip, 2025. Verfasst von Gowri Manohari Balachander und 18 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Indian Institute of Technology (BHU) Varanasi, Varanasi-221005, India. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Liver, Lab-On-A-Chip Devices. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 102 Literaturangaben. Gefördert von: Mechanobiology Institute, Singapore, National Medical Research Council, Science and Engineering Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The key elements in the development of the LEADS chip are highlighted; the crucial features of the chip for mimicking NASH in vitro and its applicability as a pre-clinical drug testing model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseLiverLab-On-A-Chip DevicesHumansDrug Evaluation, Preclinical

Autor:innen und Institutionen

  • School of Biomedical Engineering, Indian Institute of Technology (BHU) Varanasi, Varanasi-221005, India.
  • Department of Physiology, The Institute for Digital Medicine (WisDM), Yong Loo Lin School of Medicine, MD9-04-11, 2 Medical Drive, Singapore 117593, Singapore.
  • Bioprinting Lab, Department of Dermatology, Dr. D.Y. Patil Medical College, Hospital & Research Centre, Sant Tukaram Nagar, Pimpri, Pune, Maharashtra, India.
  • Biomedical Sciences Industry Partnership Office (BMSIPO), A*STAR, 31 Biopolis Way, 138669, Singapore.
  • Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore.
  • Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore.

Förderung

  • Mechanobiology Institute, Singapore
  • National Medical Research Council
  • Science and Engineering Research Board
  • Biomedical Research Council
  • Agency for Science, Technology and Research

Zitieren

APA

Balachander, G. M., Ng, I. C., Pai, R. R., Mitra, K., Tasnim, F., Lim, Y. S., Kwok, R., Song, Y., Yaw, L. P., Quah, C. B., Zhao, J., Septiana, W. L., Kota, V. G., Teng, Y., Zheng, K., Xu, Y., Lim, S. H., Ng, H. H., & Yu, H. (2025). LEADS – a comprehensive human liver-on-a-chip for non-alcoholic steatohepatitis (NASH) drug testing. Lab on a Chip, 25(14), 3444-3466. https://doi.org/10.1039/d5lc00221d

Vancouver

Balachander GM, Ng IC, Pai RR, Mitra K, Tasnim F, Lim YS, et al. LEADS – a comprehensive human liver-on-a-chip for non-alcoholic steatohepatitis (NASH) drug testing. Lab on a Chip. 2025;25(14):3444-3466. doi:10.1039/d5lc00221d

BibTeX
@article{Balachander2025,
  author = {Balachander, Gowri Manohari and Ng, Inn Chuan and Pai, Roopesh R and Mitra, Kartik and Tasnim, Farah and Lim, Yee Siang and Kwok, Royston and Song, Yoohyun and Yaw, Lai Ping and Quah, Clarissa Bernice and Zhao, Junzhe and Septiana, Wahyunia L and Kota, Vishnu Goutham and Teng, Yao and Zheng, Kexiao and Xu, Yan and Lim, Sei Hien and Ng, Huck Hui and Yu, Hanry},
  title = {LEADS – a comprehensive human liver-on-a-chip for non-alcoholic steatohepatitis (NASH) drug testing},
  journal = {Lab on a Chip},
  year = {2025},
  volume = {25},
  number = {14},
  pages = {3444--3466},
  doi = {10.1039/d5lc00221d}
}
Kostenlos starten →